Akèy › Maladi Entestinal Anflamatwa › Georgia
Etid klinik pou Maladi Entestinal Anflamatwa nan Georgia
9 etid pou Maladi Entestinal Anflamatwa ap chèche patisipan nan sit nan Georgia.
Vil nan Georgia
Tèks ofisyèl etid la (Anglè)
A Study of Guselkumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, Atlanta
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Sep 25, 2026 · NCT05923073A Phase 2 Study to Evaluate MORF-057 in Adults With Moderately to Severely Active Crohn's Disease
- Atlanta Gastroenterology Specialists, PC, Atlanta
- Atlanta Gastroenterology Associates (Part of United Digestive), Atlanta
Ap rekriteFaz 2
Laj 18 a 85 · Tout sèks · Mizajou Sep 22, 2026 · NCT06226883A Master Protocol (AMAZ): A Study of Mirikizumab (LY3074828) in Pediatric Participants With Ulcerative Colitis or Crohn's Disease (SHINE-ON)
- Emory University School of Medicine, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
Ap rekriteFaz 3
Laj 2 a 19 · Tout sèks · Mizajou Sep 22, 2026 · NCT04844606Proof of Concept Study Evaluating the Efficacy and Safety of ATH-063 Treatment in Patients With Relapsed/Refractory Moderately to Severely Active Ulcerative Colitis (UC)
- Gastroenterology Consultants, P.C., Roswell
Ap rekriteFaz 2
Laj 18 a 75 · Tout sèks · Mizajou Sep 21, 2026 · NCT07513181A Study of Mirikizumab (LY3074828) in Pediatric Participants With Crohn's Disease
- Emory University, Atlanta
- Children's Center for Digestive Health Care, LLC, Atlanta
Ap rekriteFaz 3
Laj 2 a 17 · Tout sèks · Mizajou Aug 24, 2026 · NCT05509777Clinical, Imaging, and Endoscopic Outcomes of Children Newly Diagnosed With Crohn's Disease
- Emory University, Atlanta
Ap rekriteFaz 4
Laj 6 a 17 · Tout sèks · Mizajou May 27, 2026 · NCT05781152Heart Rate Variability and Inflammatory Bowel Disease
- Atlanta Metropolitan Area, Atlanta
- Children's Healthcare of Atlanta, Atlanta
- Center for Advanced Pediatrics, Atlanta
Ap rekrite
Laj 13 a 18 · Tout sèks · Mizajou Apr 1, 2026 · NCT06537258A Phase 2 Study to Evaluate Therapies for Inflammatory Bowel Disease
- Mirador Therapeutics Selected Site, Atlanta
- Mirador Therapeutics Selected Site, Snellville
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Mar 12, 2026 · NCT07113522Testing the Impact of Measurement-Based Care on Quality of Life and Disease Management Among Veterans With Inflammatory Bowel Disease
- Atlanta VA Medical and Rehab Center, Decatur, GA, Decatur
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 11, 2026 · NCT07210580Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.